Stomach Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Three genes (CHRM2, FAM5C and MYLK) were further confirmed to show methylation rates increased with progression from NC to GPL, then to GC.
|
22377736 |
2012 |
Atrial Fibrillation
|
0.010 |
Biomarker
|
disease |
BEFREE |
An antibody for the muscarinic M2 receptor is related to atrial fibrillation, an antibody targeting Na-K-ATPase is closely related to sudden cardiac death from fatal ventricular arrhythmias, and an autoantibody for troponin I increases the L-type calcium current and is related to myocardial damage.
|
21617318 |
2011 |
Alcohol or Other Drugs use
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
These results suggest that CHRM2 variants are potentially relevant for adolescent substance use and that temperamental risk factors could contribute to these associations.
|
21494862 |
2011 |
Nicotine Dependence
|
0.010 |
Biomarker
|
disease |
BEFREE |
The impact of three SNPs in CHRM2 on smoking behavior/nicotine addiction was investigated using logistic regression models or a quasi-Poisson regression model, respectively.
|
19644963 |
2010 |
Addictive Behavior
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Our data provide further evidence that variations in CHRM2 may be associated with the genetic risk of addiction in general or with certain personality traits that predispose to the development of addiction.
|
19644963 |
2010 |
Recurrent major depressive episodes
|
0.010 |
Biomarker
|
disease |
BEFREE |
Depression Case Control (DeCC) Study fails to support involvement of the muscarinic acetylcholine receptor M2 (CHRM2) gene in recurrent major depressive disorder.
|
19181679 |
2009 |
Acute myocardial infarction
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
DNA sequence variation at the CHRM2 locus is a determinant of cardiac autonomic function in the postexercise early recovery phase and predicts cardiac mortality after AMI.
|
18979273 |
2009 |
Cardiomyopathy, Dilated
|
0.010 |
Biomarker
|
group |
BEFREE |
Circulating autoantibodies against the M2-muscarinic acetylcholine receptor (CHRM2) have been detected in patients with dilated cardiomyopathy (DCM).
|
18451336 |
2008 |
Cardiomyopathy, Dilated
|
0.010 |
GeneticVariation
|
group |
LHGDN |
A missense mutation in the CHRM2 gene is associated with familial dilated cardiomyopathy.
|
18451336 |
2008 |
Cardiomyopathy, Familial Idiopathic
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Linkage analysis demonstrated cosegregation of the microsatellite markers, D7S509 and D7S495 that flank the CHRM2 gene, with the familial form of DCM.
|
18451336 |
2008 |
Anoxia
|
0.010 |
Biomarker
|
phenotype |
LHGDN |
Transient hypoxia induces sequestration of M1 and M2 muscarinic acetylcholine receptors.
|
16336219 |
2006 |
Mental disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
These findings provide strong evidence that variants within or close to the CHRM2 locus influence risk for two common psychiatric disorders.
|
15229186 |
2004 |
Abnormal behavior
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
These findings provide strong evidence that variants within or close to the CHRM2 locus influence risk for two common psychiatric disorders.
|
15229186 |
2004 |
Obesity
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
p.R270H (rs116454156) in the long chain fatty acid 7TM receptor FFAR4 (GPR120) which results in impaired Gαq (Gq) coupled signalling, has been associated with obesity.
|
27068006 |
2016 |
Asthma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Two of the seven SNPs located in CHRM2, the 3' untranslated region rs8191992 and rs6962027, differed significantly in allele frequencies between patients with asthma and healthy controls [odds ratio (OR) 1.42, 95 % confidence interval (95 % CI) 1.14-1.77, P = 0.001, and OR 1.50, 95 % CI 1.21-1.87, P = 0.0002, respectively].
|
24430298 |
2014 |
Obesity
|
0.020 |
Biomarker
|
disease |
BEFREE |
CHRM2 genotypic variance predicted longitudinal BMI and obesity status.
|
25155933 |
2014 |
Unipolar Depression
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
This group also showed a greater prevalence of a CHRM2 genotype previously associated with substance dependence and Major Depressive Disorder as well as a modest elevation on a non-planning impulsiveness scale.
|
24530440 |
2014 |
Familial dilated cardiomyopathy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Previously, we reported a missense mutation (C722G) in the M2-muscarinic acetylcholine receptor (CHRM2) gene associated with familial dilated cardiomyopathy.
|
23743182 |
2013 |
Familial dilated cardiomyopathy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
A missense mutation in the CHRM2 gene is associated with familial dilated cardiomyopathy.
|
18451336 |
2008 |
Depressive Syndrome
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Genet., 13, 1903-1911] reported that variation in CHRM2 gene predisposed to alcohol dependence (AD) and major depressive syndrome.
|
16000316 |
2005 |
Depressive Syndrome
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome.
|
15229186 |
2004 |
Asthma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
One immunological component of asthma is believed to be the interaction of eosinophils with parasympathetic cholinergic nerves and a consequent inhibition of acetylcholine muscarinic M2 receptor activity, leading to enhanced acetylcholine release and bronchoconstriction.
|
12948933 |
2003 |
Unipolar Depression
|
0.020 |
Biomarker
|
disease |
BEFREE |
Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major depression in women.
|
12116189 |
2002 |
Alzheimer's Disease
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Neuropsychiatric behaviours in Alzheimer's disease (AD) patients have been associated with neocortical alterations of presynaptic cholinergic and muscarinic M2 receptor markers.
|
18373228 |
2008 |
Alzheimer's Disease
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Down-regulation of muscarinic acetylcholine receptor M2 adversely affects the expression of Alzheimer's disease-relevant genes and proteins.
|
16181410 |
2005 |